Welcome to the CRTvirtual Industry Pavilions. We invite fellows and interventional cardiologists to explore the pavilions and discover spaces where companies share information about their products, provide in-depth educational information, the latest in trial data, showcase their latest offerings, and allow you to connect with industry partners.
If you are interested in sponsoring the CRTvirtual Fellows Course or an industry pavilion, please contact Debbie Schapiro.
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.
Abiomed (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. CEO, Chairman, and President Michael R. Minogue has focused the company’s efforts on developing ground-breaking technologies designed to improve the patient outcomes focused on native heart recovery. Founded in 1981 for the purpose of developing the world’s first artificial heart, Abiomed has remained dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
Asahi Intecc is a medical device company focused on delivering clinically unique devices used in vascular procedures by interventional cardiologists, interventional radiologists, vascular surgeons and neurovascular surgeons. Asahi will leverage its four core competencies to develop device-based solutions targeting specific niches where Asahi can achieve a market leading position.
Baylis Medical is a leader in the development and commercialization of innovative medical devices in the field of cardiology, with a focus on left-heart access. Headquartered in Canada, and with offices world-wide, our clinical solutions have been Improving the Lives of People Around the World for over 30 years.
BIOTRONIK is a medical technology company that develops trusted and innovative cardiovascular and endovascular solutions. Driven by purpose and integrity, BIOTRONIK has partnered with hospitals and health systems for nearly 60 years, helping to deliver care that saves and improves the lives of millions of patients with heart and blood vessel diseases.
Boston Scientific transforms lives through innovative solutions that improve the health of patients around the world. As a global medical technology leader for over 40 years, we advance science for life by providing a broad range of performance solutions that address unmet patient needs and reduce the cost of health care.
Cordis, A Cardinal Health company, is a worldwide leader in the development and manufacture of interventional vascular technology, with a reputation for clinical acumen, training and services. For more than 60-years, Cordis has delivered revolutionary products to treat millions of patients. With an established a legacy of innovation in high-quality and less-invasive cardiovascular products, Cordis has built a strong global footprint with operations in countries around the world. Our focus is on cardiology and endovascular platforms, with high-quality products such as diagnostic and interventional catheters, balloons, self-expanding stents, guide wires, and vascular closure devices.
CSI is committed to providing physicians around the world with innovative solutions for the revascularization of patients with complex coronary and peripheral artery disease. Through enhancing current technologies, developing new products, robust medical education, superior clinical evidence, and leveraging industry partnerships, we are broadening our end-to-end cardiovascular intervention solutions to help treat more patients worldwide.
KENGREAL® (cangrelor) for Injection is a P2Y12 platelet inhibitor indicated as an adjunct to percutaneous coronary intervention (PCI) to reduce the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor.
At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 75 million people a year and support our Mission to alleviate pain, restore health, and extend life.
Philips is the leader in image guided therapy solutions and industry leading devices. Philips Image Guided Therapy portfolio uniquely integrates best-in-class imaging systems and software, with specialized diagnostic and therapeutic devices to support optimal treatment for even the most complex procedures. Philips’ vision is to provide integrated solutions that advance minimally invasive procedures by helping healthcare providers decide, guide, treat and confirm the right therapy, for the right patient at the point of care. Working together with clinicians to realize this vision, Philips can help save and improve lives and reduce the total cost of care by making therapy more efficient, more appropriate and more personal.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.